Dexcom shares plummeted over 40% due to a revenue forecast cut linked to a problematic salesforce restructuring. The changes led to fewer new patients and boosted competition from Abbott and Medtronic. This wiped out $25.45 billion of Dexcom’s market value.

Dexcom plunges as revenue forecast cut spooks investors

We recommend Buy on Lupin, Aurobindo, Cipla, Abbott India, and KIMS

Pharma Q1 Results Preview - High Value Products Outpacing Price Erosion: Axis Securities

💎जैन सा'ब के GEMS...

आज Abbott India को क्यों चुना संदीप जैन ने ?

संदीप जैन से जानिए कंपनी के फंडामेंटल्स, तेजी के ट्रिगर्स और टार्गेट..

AnilSinghvi  #StockMarket #StockToWatch 


About Zee Business:

Zee Business is India's Number 1 Hindi business news channel. It's your channel for profit and wealth. Watch Live coverage of Indian markets - Sensex & Nifty, also for expert insights and advise from our team of experts.
 
--------------------------------------------------------------
Subscribe Zee Business: https://bit.ly/3L6GG0C
 
Business की हर बड़ी ख़बर से रहें अपडेट फॉलो करें ZEE Business का WhatsApp चैनल:   https://bit.ly/3RvzK1N

You Can Also Visit Our Website at: 

Zee Business: https://www.zeebiz.com/
Zee News: https://zeenews.india.com/
DNA India:-https://www.dnaindia.com/
WION: https://www.wionews.com/ 

Follow Us On: 
  
Facebook: https://goo.gl/OMJgrn
Twitter: https://goo.gl/OjOzpB 
Download Zee News App : https://bit.ly/ZeeNewsApps

Jain Saab Ke Gems | Why Did Sandeep Jain Choose Abbott India

Addressing the global STEM worker shortage, Abbott plans to create opportunities for over 1,00,000 youths, including 50% from underrepresented groups, to participate in STEM programmes and internships by 2030.

Abbott eyes 45% female representation in management team, 1 lakh youths in STEM programmes by 2030

Stocks On TheMove | Hormaz Fatakia is here with the trending stocks to watch out for today, May 10, 2024

#sbi #bpcl #abbottindia #abbott #mgl #relaxo #gopalsnacks #cipla #eichermotors #tatamotors #lic #manappuramfinance #stocksinfocus #stockmarket #stockmarketnews #stockmarketupdates #cnbctv18digital #cnbctv18 
#businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday   

🔴CNBC TV18 LIVE TV: https://youtube.com/live/P857H4ej-MQ
SUBSCRIBE to our Channel: https://bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
👑 Check Out Top CNBC TV18 Playlist Videos: 
   
🔹Lok Sabha Elections 2024: https://www.youtube.com/playlist?list=PLjq9mRS1PfGC0rKWJ57LWAs_ytML7x4CD

🔹CNBC TV18 Digital Podcast: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCUcGVQvYyDQ6VVHoo3ZDKJ

🔹Sounding Board: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBbB2dV2tyHdzx_k9EqvVEm 

🔹International Videos: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDZ-Dkz-VpCDqqmWThJ3YJw

🔹CNBC TV18 Market Cafe: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDANftdnJchuL-WPpSv5rmH

🔹CNBC TV18 Digital: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDLhtM8FzErPcjmJRQ4I5cZ

🔹CNBC TV18 Weekend Special: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBHEa5NnoKuUsX5GwxEGuri

🔹CNBC TV18 Next-Gen: https://www.youtube.com/playlist?list=PLjq9mRS1PfGA6roe9q3J9fq_gBIDjX2w7

🔹Overdrive Show: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCnSVjfbWfNCJLrv-CqfGmH

🔹Young Turks: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBZaN1e38X2ZmevnU1e1NJs

🔹Starup Streets: https://www.youtube.com/playlist?list=PLjq9mRS1PfGD3CzrtMr_VJRbIly6sfyFI

------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Follow us on Instagram: https://www.instagram.com/cnbctv18india/
Catch us on: Linkedin: https://in.linkedin.com/company/cnbc-tv18
n18oc_business

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.

Stocks On The Move | Top Shakers & Movers Of The Day | N18S | CNBC TV18

Aggressive long positions were built in Piramal Enterprises, Abbott India, Torrent Pharmaceuticals, Tata Consumer Products and Colgate Palmolive on the monthly expiry day i.e 28 March.

New buy signal generated in these 4 F&0 scrips as per RMI scanner

The pharmaceutical company’s consolidated net profit rose 26% year-on-year to Rs 311 crore in the quarter ended December, beating Bloomberg’s estimate of Rs 289.7 crore.

Abbott India Q3 Profit Beats Estimates, Propels Shares Over 9% To Record High

Based on the OI percentage, 75 stocks were on the short-covering list. This included Hindustan Copper, Tata Chemicals, Astral, IDFC First Bank, and Abbott India.

Trade setup for Tuesday: 15 things to know before opening bell

The public notice issued by the apex drug controller on its website said: “The impugned product may be unsafe and its use may result in adverse reaction.”

Drugs regulator issues alert after pharma firm Abbott India recalls antacid syrup Digene Gel

The Mumbai-based company is voluntarily recalling batches, especially of the mint and orange-flavoured syrup. Also, the company has decided to voluntarily stop the production of all variants of Digene Gel manufactured at their Goa facility

Abbott India Recalls Batches of Popular Antacid Digene Gel After Complaint of Foul Taste & Odour - News18

Pharmaceutical companies must prioritize responsible manufacturing to combat AMR and limit environmental impact. A handful of companies are taking promising action, such as Abbott, Centrient, Sandoz, Shionogi, Aurobindo, Cipla, Viatris and Sun Pharma.

Responsible manufacturing critical to keep AMR in check: Study

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Abbott India is a healthcare company engaged in pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

Abbott India Ltd